The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease (Q28373127)
scientific article
Language:
Current Data About The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease
(P31) (Q13442814)

(P304) 744-53

(P407) (Q1860)

(P433) 5

(P478) 14

(P577) +1999-09-00T00:00:00Z

(P921) (Q11085)
(P887)

(Q629444)
(P887)

(P1433) (Q1486418)

(P1476) "The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease" (language: en)

(P2093) B Henry
(P1545) 1

S H Fox
(P1545) 2

D Peggs
(P1545) 3

A R Crossman
(P1545) 4

J M Brotchie
(P1545) 5

(P2860) (Q38139938)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q39457341)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q48311680)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q39392327)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q33756251)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q37016294)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q39484715)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q54384818)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q39234620)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q42282601)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q51125505)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q35873531)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q24317175)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q42526623)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q34248096)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q34253055)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q42554799)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q42285088)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q42541635)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q52881733)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q28295664)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q42241974)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q41049307)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q37585084)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q33247170)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

(Q35026368)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1531-8257%28199909%2914%3A5%3C744%3A%3AAID-MDS1006%3E3.0.CO%3B2-7
(P813) Sunday, January 21, 2018

other details